UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 715

Sortiert nach

Efficacy and Safety of Sofosbuvir‐Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation

American journal of transplantation, 2016-05, Vol.16 (5), p.1474-1479

2016

Link zum Volltext

Verfügbarkeit prüfen

Transplantation rénale robotique « sans incision » : insertion du rein par voie vaginale avec reconstruction vaginale endocorporelle

Progrès en urologie (Paris), 2015-11, Vol.25 (13), p.866-867

2015

Link zum Volltext

Verfügbarkeit prüfen

Long‐Term Outcomes in Belatacept‐ Versus Cyclosporine‐Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT‐EXT, a Phase III Randomized Study

American journal of transplantation, 2016-11, Vol.16 (11), p.3192-3201

2016

Link zum Volltext

Verfügbarkeit prüfen

Novel Once‐Daily Extended‐Release Tacrolimus (LCPT) Versus Twice‐Daily Tacrolimus in De Novo Kidney Transplants: One‐Year Results of Phase III, Double‐Blind, Randomized Trial

American journal of transplantation, 2014-12, Vol.14 (12), p.2796-2806

2014

Link zum Volltext

Verfügbarkeit prüfen

Reduction of Extended‐Release Tacrolimus Dose in Low‐Immunological‐Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor‐Specific Antibodies: A Randomized Study

American journal of transplantation, 2017-05, Vol.17 (5), p.1370-1379

2017

Link zum Volltext

Verfügbarkeit prüfen

Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients

American journal of transplantation, 2012-01, Vol.12 (1), p.210-217

2012

Link zum Volltext

Verfügbarkeit prüfen

Renal transplantation

Néphrologie & thérapeutique, 2017-06, Vol.13 (6S), p.S25

Rostaing, L

2017

Link zum Volltext

Verfügbarkeit prüfen

How Should Hepatitis E Virus Infection Be Defined in Organ‐Transplant Recipients?

American journal of transplantation, 2013-07, Vol.13 (7), p.1935-1936

2013

Link zum Volltext

Verfügbarkeit prüfen

Effets de la stimulation transcrânienne à courant direct sur la douleur et la consommation d’opioïdes après une chirurgie de la colonne vertébrale

Douleur et analgésie, 2023-03, Vol.36 (1), p.46-56

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, Incidence and Risk Factors for Donor‐Specific Anti‐HLA Antibodies in Maintenance Liver Transplant Patients

American journal of transplantation, 2014-04, Vol.14 (4), p.867-875

2014

Link zum Volltext

Verfügbarkeit prüfen

Épisodes d’hypoglycémies répétées après transplantation rein–pancréas chez des diabétiques de type 1

Annales d'endocrinologie, 2012-09, Vol.73 (4), p.395-395

2012

Link zum Volltext

Verfügbarkeit prüfen

Conversion From Twice‐Daily Tacrolimus to Once‐Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial

American journal of transplantation, 2013-03, Vol.13 (3), p.760-769

2013

Link zum Volltext

Verfügbarkeit prüfen

Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged‐Release Tacrolimus Regimens—The DIAMOND Study

American journal of transplantation, 2015-07, Vol.15 (7), p.1843-1854

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

American journal of transplantation, 2010-03, Vol.10 (3), p.535-546

2010

Link zum Volltext

Verfügbarkeit prüfen

Protracted Fecal Shedding of HEV During Ribavirin Therapy Predicts Treatment Relapse

Clinical infectious diseases, 2015-01, Vol.60 (1), p.96-99

2015

Link zum Volltext

Verfügbarkeit prüfen

Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study

Journal of the American Society of Nephrology, 2022-04, Vol.33 (4), p.829-838

2022

Link zum Volltext

Verfügbarkeit prüfen

Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation

American journal of transplantation, 2007-11, Vol.7 (11), p.2496-2503

2007

Link zum Volltext

Verfügbarkeit prüfen

Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study

American journal of transplantation, 2013-11, Vol.13 (11), p.2875-2883

2013

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney‐Transplant Patients

American journal of transplantation, 2010-01, Vol.10 (1), p.89-98

2010

Link zum Volltext

Verfügbarkeit prüfen

Delayed Introduction of Reduced‐Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT' Study

American journal of transplantation, 2009-02, Vol.9 (2), p.327-336

2009

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis

American journal of transplantation, 2015-01, Vol.15 (1), p.190-199

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease

BMC nephrology, 2018-09, Vol.19 (1), p.241-241, Article 241

2018

Link zum Volltext

Verfügbarkeit prüfen

20% of living donor kidney transplantation in France? Yes, it's possible!

Néphrologie & thérapeutique, 2013-12, Vol.9 (7), p.459

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation

Thrombosis research, 2018-06, Vol.166, p.113-121

2018

Link zum Volltext

Verfügbarkeit prüfen

Belatacept‐Based Immunosuppression in De Novo Liver Transplant Recipients: 1‐Year Experience From a Phase II Randomized Study

American journal of transplantation, 2014-08, Vol.14 (8), p.1817-1827

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 715

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(585)
Mit Volltextzugriff
(531)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(337)
Humans
(311)
Life Sciences & Biomedicine
(294)
Biological And Medical Sciences
(206)
Male
(203)
Medical Sciences
(198)
Middle Aged
(198)
Female
(183)
Transplantation
(178)
Adult
(172)
Surgery
(143)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(121)
Kidney Transplantation
(118)
Immunology
(98)
Aged
(92)
Urology & Nephrology
(88)
Immunosuppressive Agents - Therapeutic Use
(82)
Fundamental And Applied Biological Sciences. Psychology
(72)
Treatment Outcome
(58)
Surgery Of The Urinary System
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Sofosbuvir‐Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation

Transplantation rénale robotique « sans incision » : insertion du rein par voie vaginale avec reconstruction vaginale endocorporelle

Long‐Term Outcomes in Belatacept‐ Versus Cyclosporine‐Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT‐EXT, a Phase III Randomized Study

Novel Once‐Daily Extended‐Release Tacrolimus (LCPT) Versus Twice‐Daily Tacrolimus in De Novo Kidney Transplants: One‐Year Results of Phase III, Double‐Blind, Randomized Trial

Reduction of Extended‐Release Tacrolimus Dose in Low‐Immunological‐Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor‐Specific Antibodies: A Randomized Study

Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients

Renal transplantation

How Should Hepatitis E Virus Infection Be Defined in Organ‐Transplant Recipients?

Effets de la stimulation transcrânienne à courant direct sur la douleur et la consommation d’opioïdes après une chirurgie de la colonne vertébrale

Prevalence, Incidence and Risk Factors for Donor‐Specific Anti‐HLA Antibodies in Maintenance Liver Transplant Patients

Épisodes d’hypoglycémies répétées après transplantation rein–pancréas chez des diabétiques de type 1

Conversion From Twice‐Daily Tacrolimus to Once‐Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial

Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged‐Release Tacrolimus Regimens—The DIAMOND Study

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

Protracted Fecal Shedding of HEV During Ribavirin Therapy Predicts Treatment Relapse

Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study

Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation

Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study

Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney‐Transplant Patients

Delayed Introduction of Reduced‐Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT' Study

Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis

Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease

20% of living donor kidney transplantation in France? Yes, it's possible!

Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation

Belatacept‐Based Immunosuppression in De Novo Liver Transplant Recipients: 1‐Year Experience From a Phase II Randomized Study

Suchergebnisse filtern